Promise of Mesenchymal Stem Cell Lysates in IBD Therapy: Are the Parts Greater than the Whole?

Dig Dis Sci. 2021 Apr;66(4):932-934. doi: 10.1007/s10620-020-06473-2.

Authors

Victoria Gudiño¹, Azucena Salas²

Affiliations

¹ Inflammatory Bowel Disease Unit, Department of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer, CIBER-EHD, Rosselló 149-153, 08036, Barcelona, Spain.
² Inflammatory Bowel Disease Unit, Department of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer, CIBER-EHD, Rosselló 149-153, 08036, Barcelona, Spain. [email protected].

PMID: 32691380
DOI: 10.1007/s10620-020-06473-2

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Inflammatory Bowel Diseases* / drug therapy
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*